Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNNMedical - Instruments & Supplies
+$0.37 today
- Market cap
- $158.01M
- Beta
- 4.34
- P/E (TTM)
- 99.1
- EPS (TTM)
- $0.16
Volume 0.09M
Average 0.03M
NNNN Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
Anbio Biotechnology Class A Ordinary SharesNASDAQ: NNNN
Goodwill · Q4 FY2025 · quarter ended Dec 2025
Goodwill remains negative
Q4 FY2025 goodwill was $0, compared with $0 a year earlier.
Context
- Goodwill amounted to 0.0% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
- Goodwill increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Goodwill vs competitors
How NNNN compares with its peers on the latest reported figures
- Peers report in different currencies, so goodwill is compared through growth and share of total assets rather than absolute size.
- Goodwill amounts to 0.0% of total assets for NNNN, versus a peer median of 1.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.13B USD | -17.3% | -7.3% | 23.7% | |
| Mar 2026 | $394M USD | -13.6% | -19.6% | 37.5% | |
| Mar 2026 | CA$127.17M CAD | +2.4% | +22.7% | 9.7% | |
| Mar 2026 | $7.47M USD | — | — | 8.0% | |
| Mar 2026 | $3.43M USD | — | — | 2.5% | |
NNNNAnbio Biotechnology Class A Ordinary Shares | Dec 2025 | $0 USD | — | — | 0.0% |
| Dec 2025 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Feb 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NNNN) | — | -13.6% | -7.3% | 1.3% | |
Competitors are the stored peer set for NNNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Intrinsic Alpha fair value
Locked
Current Price
$3.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.